COSCIENS Biopharma's market cap is currently ―. The company's EPS TTM is $-26.087; its P/E ratio is ―; COSCIENS Biopharma is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 1.87M	$ 2.34M	$ 4.00K	$ 121.00K	$ 3.00K
Gross Profit	$ 957.00K	$ 819.00K	$ -12.00K	$ 288.00K	$ -8.00K
EBIT	$ -5.84M	$ -1.87M	$ -5.75M	$ -5.64M	$ -4.14M
EBITDA	$ -5.41M	$ -1.50M	$ -5.70M	$ -5.77M	$ -4.10M
Net Income Common Stockholders	$ -5.75M	$ -1.42M	$ -5.75M	$ -5.63M	$ -4.14M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 20.00M	$ 27.80M	$ 29.55M	$ 34.02M	$ 38.76M
Total Assets	$ 43.77M	$ 50.05M	$ 31.79M	$ 37.02M	$ 42.49M
Total Debt	$ 1.62M	$ 1.69M	$ 234.00K	$ 279.00K	$ 217.00K
Net Debt	$ -18.38M	$ -26.12M	$ -29.31M	$ -33.74M	$ -38.54M
Total Liabilities	$ 23.75M	$ 23.82M	$ 18.82M	$ 18.82M	$ 16.21M
Stockholders Equity	$ 20.01M	$ 26.23M	$ 12.97M	$ 18.20M	$ 26.28M
Cash Flow	-
Free Cash Flow	$ -7.91M	$ -1.56M	$ -4.42M	$ -6.03M	$ -3.39M
Operating Cash Flow	$ -7.78M	$ -1.40M	$ -4.42M	$ -6.03M	$ -3.38M
Investing Cash Flow	$ 83.00K	$ 25.88M	$ -5.00K	$ 543.00K	$ -10.00K
Financing Cash Flow	$ -188.00K	$ -126.00K	$ -42.00K	$ -38.00K	$ -33.00K

Currency in USD

COSCIENS Biopharma Earnings and Revenue History

Income Statement >

COSCIENS Biopharma Debt to Assets

Balance Sheet >

COSCIENS Biopharma Cash Flow

Cash Flow >

COSCIENS Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing